1st Quarter - Report — PREVENT BLINDNESS for PREVENT BLINDNESS (2008)

Firm

PREVENT BLINDNESS

Client

PREVENT BLINDNESS

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General research and prevention health appropriations.

Lobbyist	Covered position, as disclosed
DANIEL GARRETT	—

Contacted: Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.